The expression and function of the newly identified Bcl-2-and Raf-1-binding protein, Bag-1, during the cytokine-regulated growth of B and T cell lines was examined. Immunoblot analysis of lysates from the interleukin-3 (IL-3)-dependent B cell line Ba/F3, and the PRL-dependent T cell line Nb2, revealed that variations in Bag-1 levels paralleled alterations in cellular proliferation, viability, and apoptosis induced by the presence or absence of growth factor. To test whether up-regulation of Bag-1 levels altered cellular survival and proliferation, Ba/F3 cells were transfected with a Bag-1 expression construct. The overexpression of Bag-1 in transfected Ba/F3 cells induced an IL-3-independent state. Such transfectants demonstrated sustained viability and proliferation, with minimal apoptosis, in the complete absence of exogenous IL-3. Bag-1 expression was also compared in glucocorticoid-sensitive Nb2 cells and a PRL-independent, glucocorticoid-resistant subline, SFJCD1, during culture of these lines in dexamethasone (Dex). Bag-1 levels were profoundly decreased by the addition of Dex to Nb2 cells, precedent to the onset of apoptotic cell death. In contrast, Dex treatment or PRL withdrawal had no effect on levels of Bag-1 within the SFJCD1 line. These findings establish that the overexpression of Bag-1 in the appropriate cellular context promotes cellular survival and growth, events that may result from the juxtaposition of this protein with mitogenic and antiapoptotic signaling pathways. (Molecular Endocrinology 11: 608-618, 1997)
INTRODUCTION
The expansion of hematopoietic progenitors and effectors, mediated by peptide growth factors, is required during an effective immune response. This selective growth within the hematopoietic system occurs as the summation of increased cellular proliferation and decreased programmed cell death or apoptosis (1) (2) (3) . Two peptide growth factors that control such growth are interleukin-3 (IL-3) and PRL. IL-3 has been found to increase the proliferation of most hematopoietic precursors (4) and improve cellular survival by inhibiting apoptosis (1, 5, 6) . IL-3 acts as an immune stress factor, released by activated T lymphocytes and mast cells, thereby mediating a paracrine up-regulation of the pool of hematopoietic progenitors (4) . Like IL-3, PRL is also a peptide stress factor, whose secretion from the pituitary and activated T cells is increased during an immune response. PRL is necessary for both in vitro (7) (8) (9) (10) and in vivo (11) (12) (13) lymphocyte proliferation. PRL is required for IL-2-driven T cell proliferation; specifically, signals supplied from the PRL receptor (PRLR) complex drive progression from G1 to S phase of the cell cycle (14, 15) . In addition, PRL has been found to inhibit dexamethasone (Dex)-driven apoptosis of lymphocyte progenitors (16) (17) (18) . Thus, IL-3 and PRL may contribute to the overall immmunoresponsiveness through their regulation of lymphocyte apoptosis.
The regulatory role of apoptosis extends to many other aspects of the immune response. The elimination of autoreactive lymphocyte precursors, the lysis of target cells by cytotoxic T lymphocytes, and the loss of CD4ϩ T cells during infection with human immunodeficiency virus are mediated, in part, by apoptosis (19, 20) . Although the intracellular mechanisms that effect such cell death are incompletely characterized, members of the Bcl-2 (for B cell lymphoma-2) family of genes are thought to serve as central regulators of these phenomena (20) (21) (22) . Overexpression of Bcl-2 inhibits lymphocyte apoptosis initiated by several disparate stimuli including the Fas ligand (23) (24) (25) , T cell cytolysis (26) , glucocorticoids (27) (28) (29) (30) , chemotherapy (31) , and growth factor withdrawal (32) (33) (34) . Although the linkages between Bcl-2 and the downstream factors that directly effect apoptosis are incompletely characterized (35) , Bcl-2 function is significantly modulated by heterodimerization with other Bcl-2 family members (36) (37) (38) . For example, the extent of Bcl-2 and Bax homo-and heterodimerization is thought to contribute to the control of cellular survival. In addition to Bcl-2 family members, other proteins, most notably Bag-1, have been found to interact with Bcl-2 and modulate its function. Bag-1 (for Bcl-2-associated anti-death gene 1) was identified by the screening of a murine embryo cDNA library with recombinant Bcl-2 (39) . The significance of the in vitro and in vivo interaction of Bag-1 with Bcl-2 was confirmed by overexpression of Bag-1 in Jurkat and NIH3T3 cells. Overexpression of Bag-1 promoted the survival of these transfectants to a variety of apoptotic stimuli. Thus, the multimeric interactions of the Bcl-2/Bag-1/Bax complex, as regulated by the stoichiometry of its constituents, may significantly affect cellular survival.
Despite the linkage between Bcl-2 family overexpression and apoptosis, little is known of the regulation of these gene products in nontransfected cell lines experiencing stimuli that trigger cell death. If the regulation of such protein levels is central to the control of apoptosis, such changes, at the protein level, should be detectable by biochemical analysis either preceding and/or during entry into the apoptotic pathway. In this study, we tested whether the expression of the Bcl-2-binding protein, Bag-1, was associated with apoptosis induced by growth factor withdrawal and/or dexamethasone treatment of cytokine-dependent lymphocyte lines Ba/F3 and Nb2. These data revealed a direct association between Bag-1 levels and cellular growth. To confirm that increased levels of Bag-1 could enhance cellular proliferation and viability during growth factor deprivation, a Bag-1 expression construct was transfected into Ba/F3. Examination of several independently obtained transfectants has revealed that overexpression of Bag-1 confers growth factor independence to the Ba/F3 line.
RESULTS

Bag-1 Expression Is Regulated during IL-3-Driven Ba/F3 Proliferation and Apoptosis
To determine whether an association existed between the levels of the Bcl-2-binding protein, Bag-1, and apoptosis induced by cytokine withdrawal, immunoblot analysis was performed on lysates obtained from the lymphocyte lines, Ba/F3 and Nb2. Significant decreases in Bag-1 levels were noted in both cell lines during withdrawal of IL-3 and PRL, respectively. To expand upon these preliminary findings, the dependence of Ba/F3 on IL-3 for cell growth (Fig. 1A) and viability (Fig. 1B) was correlated with Bag-1 expression with respect to dose and time (Fig. 1, C and D) . Ba/F3 cells cultured in the absence of IL-3 expressed 6-to 8-fold less Bag-1 than parallel cultures incubated in the presence of IL-3. This was due to a modest (50%) increase in Bag-1 levels in the IL-3-stimulated cultures and a 4-fold decrease in Bag-1 levels in IL-3-deprived cultures. As described below, the loss of cellular viability, as measured by trypan blue uptake, was found to occur shortly after the apoptosis-associated phenomena of cleavage and loss of cellular DNA (Fig. 3) . The temporal decreases in Bag-1 expression were noted to occur in rough approximation with the initiation of endonucleolytic DNA cleavage. Taken together, these data indicate an association between decreased Bag-1 expression and the onset of apoptosis.
Overexpression of Bag-1 Permits Sustained Ba/F3 Viability and Proliferation in the Absence of IL-3
To explore whether up-regulation of Bag-1 levels could inhibit cellular death induced by cytokine withdrawal, stable transfectants of Ba/F3 that constitutively expressed Bag-1 were generated. High levels of Bag-1 were observed in clones containing the Bag-1 expression construct ( Fig. 2A) , in comparison to either the parental line or control transfectants that received the same vector lacking Bag-1. Similar to the parental Ba/F3, control transfectants demonstrated significant decreases in Bag-1 levels as a function of IL-3 deprivation (Fig. 2B ). When IL-3 was withdrawn from these subclones, sustained proliferation and viability were observed in only those transfectants that overexpressed Bag-1 (Fig. 3, A and B) . Indeed, the viability of the Bag-1 transfectants in IL-3-deficient medium paralleled that of the parental line raised in medium containing IL-3 (see Fig. 1B ). Concurrent with the enhanced survival, the Bag-1 transfectants continued to proliferate in the absence of IL-3 (Fig. 3A) ; however, a cell density of approximately 2-fold greater than the parental line was reached (see Fig. 1A ). Additional studies revealed that if the IL-3-deficient medium was not changed between 48-60 h after culture initiation, the Bag-1 transfectants would demonstrate a decrease in viability and proliferation. However, thriceweekly refeeding with medium lacking IL-3 permitted continued growth and viability (Ͼ95%) for at least 2 months.
To confirm that the improvement in cell viability of the Bag-1 transfectants was secondary to a decrease in the percentage of cells undergoing apoptosis, three independent measures of programmed cell death were performed. Two of these measures, presented in sured by the incorporation of digoxigenin labeled dUTP (ddUTP) by terminal deoxynucleotide transferase (TdT)] or DNA degradation (as measured by hypodiploid DNA content of propidium iodide-stained cells). These analyses demonstrated that, in contrast to the transfected controls and the parental line, the Bag-1 transfectants had a significant reduction in the percentage of cells undergoing apoptosis as a result of IL-3 withdrawal. Further analysis of these DNA content histograms revealed an increase in the %S-phase fraction of the Bag-1 transfectants by approximately 2-fold (data not shown). Taken together, these data indicate that constitutive overexpression of Bag-1 in the Ba/F3 cell line induces an immortalized, IL-3-independent state that prevents apoptosis upon withdrawal of IL-3 and permits continued proliferation under such conditions.
Effects of PRL and Dex on Nb2 Cell Growth Viability and Apoptosis
To extend the data obtained with the Ba/F3 cells, the growth, viability, and apoptosis of PRL and Dextreated Nb2 cells were ascertained (Fig. 4) at concentrations of PRL (5 ng/ml, 0.2 nM) and Dex (100 nM) previously determined to induce maximal proliferation or apoptosis (16, 17) , respectively (Fig. 4, A  and B) The addition of Dex to Nb2 cells in the absence of exogenous PRL was found to inhibit proliferation and induce a profound decrease in viable cell number. The extent of Dex-induced apoptosis in Nb2 cells was examined with the same methodology used for Ba/F3 (Fig. 4, C and D) and confirmed that a significant increase in apoptosis (also confirmed morphologically) occurred in Dextreated cultures.
In contrast to Dex-treated Nb2 cultures, the viable cell number of Nb2 cells cultured in the presence of both exogenous PRL and Dex was relatively stationary. Concomitantly, the incidence of apoptotic death within these cultures was less marked than in cultures that received Dex only. Of note, parallel growth and viability curves were observed between cultures that received both or neither of the two hormones.
The Regulated Expression of Bag-1 Found in Nb2 Is Absent in the PRL-Independent Nb2 Subline, SFJCD1
The expression of Bag-1 in Nb2 cells was measured by immunoblot analysis (Fig. 5 ). For these experiments, Nb2 cells were deprived of PRL for 24 h and then restimulated with various concentrations of PRL or Dex before cell lysates were prepared at various time intervals and immunoblot analysis of Bag-1 was performed. The regulation of Bag-1 expression in Nb2 cells by PRL was dosedependent ( Fig. 5A) , whereas a 5-fold decrease in Bag-1 levels was observed in PRL-deficient cultures. In contrast, an inverse relationship between Bag-1 levels and Dex concentration was noted (Fig. 5B) , with an approximately 15-fold decrease in Bag-1 levels in Nb2 cultures treated with 1-3 M Dex. Further delineation of the temporal regulation of Bag-1 levels in response to concomitant PRL (5 ng/ml) and/or Dex (100 nM) stimulation is presented in Fig. 5C . These data revealed that treatment with only Dex induced a rapid decline (after 6 h) in Bag-1, with 10-fold reduction in levels by 24 h. Dex also induced decreases in Bag-1 protein levels in PRL-stimulated Nb2 cells, but the effects were less striking than in cultures that received Dex alone. Taken together, these data indicate that Bag-1 levels correlate with cell growth and apoptosis in Nb2 cells during treatment with Dex, PRL, or a combination of these reagents.
To extend these correlations further, Bag-1 levels were examined in the PRL-independent SFJCD1 Tcell line during PRL withdrawal or Dex treatment. Unlike Nb2, this PRL-independent subline is resis- Ba/F3 cells were stably transfected with Bag1-pCMV or Neo-pCMV and cultured for various times without IL-3 as indicated (A). Cell lysates from these cultures were prepared and subjected to sequential SDS-PAGE and immunoblot analysis using an anti-Bag-1 antiserum. Bag-1 levels in both the Ba/F3 parent and control Neo-pCMV transfectants decreased temporally during IL-3 deprivation (B). Levels of Bag-1 were determined by immunoblot analysis of cell lysates using an anti-Bag-1 antibody as above; the control blot represents parallel blot probed with preimmune serum. Results similar to the control clone Neo-pCMV-1 were obtained for Neo-pCMV-3 (data not shown).
tant to Dex-induced apoptosis (40, 41) . As seen in Fig. 5D , PRL withdrawal or treatment with Dex (100 nM) had little effect on Bag-1 levels or on the viability of the SFJCD1 subline, in contrast to the parental Nb2 line. These data, therefore, further confirm an association between Bag-1 levels and Nb2 growth and survival, suggesting a regulatory role for this protein in Nb2 cells, similar to that seen in Ba/F3. 
DISCUSSION
The receptors for IL-3 and PRL belong to the growth factor/cytokine receptor superfamily that is widely expressed within the hematopoietic system (42-44). Ligand stimulation of progenitor cells promotes proliferation, survival, and differentiation of select cell lineages, resulting in a coordinated immune response.
A common structure/function aspect of the growth factor receptor superfamily is its lack of intrinsic kinase activity (42) . Thus, signaling via these receptors is mediated by associated transduction factors. Signals supplied by receptor-associated kinase cascades, such as the JAK/STAT and the Ras/Raf pathways (45-50), are believed in part to transmit signals from this receptor superfamily that initiate cell cycle pro- gression. In contrast, the structure/function basis for the immediate antiapoptotic signals supplied by these receptors is incompletely understood. Nevertheless, alterations in the levels of the Bcl-2 family, induced by overexpression of transfected gene constructs (i.e.
Bcl-2 and Bax), clearly alters the survival, but not the proliferation, of cytokine-dependent cell lines (33, 36, 51) . Overexpression of the Bcl-2 gene in transgenic animals also inhibits the in vivo apoptosis of select lymphocyte progenitor populations (27, 52, 53). Taken together, these data suggest that alterations in the levels of members of the Bcl-2 family may control apoptosis by several stimuli, including growth factor/ cytokine withdrawal. Initial studies performed in our laboratory, however, revealed no significant changes in the levels of Bcl-2, Bax, or Bcl-X L proteins during stimulation with or withdrawal of growth factor from the Ba/F3 or Nb2 lines (not shown). These observations largely agree with a previous report (54) , which demonstrated modest changes in the levels of Bcl-2 and Bax protein during stimulation of Nb2 with PRL, despite the significant induction of Bcl-2 and Bax mRNA during such treatment.
In contrast to Bcl-2, Bax, and Bcl-X L , these studies indicate that the level of the Bcl-2-associated protein, Bag-1, was closely associated with the growth (i.e. the proliferation and inhibition of apoptosis) of both the Ba/F3 and Nb2 lymphocyte lines. Coexpression of Bag-1 and Bcl-2 in Jurkat T cells resulted in a synergistic improvement in cellular viability secondary to apoptotic stimuli induced by Fas, staurosporine, or cytotoxic T lymphocytes (39) . These effects were not noted in Jurkat transfectants that overexpressed Bag-1 alone. In contrast, the overexpression of Bag-1 alone in 3T3 fibroblasts was sufficient to inhibit staurosporine-induced apoptosis. These data suggest that the function of Bag-1 is influenced by its cellular environment and the nature of the apoptotic challenge. This hypothesis was further confirmed in the present study, which demonstrated that overexpression of the Bag-1 in Ba/F3 resulted in the induction of IL-3 independence. Thus, in the absence of IL-3, Bag-1 transfectants maintained high viability and continued to proliferate at a rate that exceeded that of the IL-3-stimulated parental line. Growth factor independence has been conferred on IL-3-dependent lines previously by the cotransfection of Bcl-2 and Myc (51), an effect not observed when either of these gene products was individually transfected (33, 34) . Thus, these data suggest that the functional effects of Bag-1 may extend beyond the downstream effectors of Bcl-2 action.
The ability of Bag-1 to induce factor-independent cell growth may be related to its interaction with signaling factors intimately associated with apoptosis and mitogenesis, namely Bcl-2 and Raf-1. As part of a signaling cascade widely used by the growth factor receptor superfamily, Raf is a central serine/threonine kinase that controls cell cycle-dependent gene expression via a kinase cascade that induces the phosphorylation of specific transcription factors (i.e. Myc, Jun, and p62 TCF ) (55) . These transcription factors are substrates for mitogenactivated protein kinase (56) , which in turn is a substrate for mitogen-activated kinase kinase (MEK), the only highaffinity substrate of Raf-1 known to date (57) (58) (59) . Raf-1 activity is allosterically modulated by the signaling proteins Ras, 14-3-3, and as most recently identified, Bag-1 (60) (61) (62) (63) (64) . Like 14-3-3, Bag-1 binding occurs in the carboxy terminus of Raf-1 (60) . Although this binding site represents the kinase domain of Raf-1, significant phosphorylation of Bag-1 does not occur. In vitro and in vivo data indicate, however, that this interaction up-regulates Raf-1 kinase activity (60) . Recent studies indicate that Bcl-2 and Raf-1 can be coimmunoprecipitated (32, 65, 66) and that the conserved BH4 domain within Bcl-2 is required for interaction with both Raf-1 and Bag-1. Taken together, these data suggest that the Bcl-2/Raf-1 interaction may be facilitated by Bag-1. It remains to be determined whether the Bcl-2/Raf-1/Bag-1 complex is targeted to intracellular membranes where Bcl-2 resides (67), such as the mitochondrial outer membranes, nuclear membrane, endoplasmic reticulum, etc. Furthermore, the stoichiometric relationships and functional significance of each member of the Bax/Bcl-2/Bag-1/Raf-1 vis-a-vis apoptosis requires further elaboration. It is interesting to note that the overexpression of Raf-1 in growth factor-dependent cells can induce a spectrum of changes related to cell type, ranging from growth factor independence to apoptosis (65, 66) . Thus, alterations in Bag-1 levels may directly effect the coupling and composition of the Bcl-2/Bag-1/Raf-1 complex, regulating its function during cellular proliferation and apoptosis. Decreases in Bag-1 levels (as seen in growth factor-deprived cells), therefore, may lead to an uncoupling of the complex and decreased viable cell growth. Conversely, the increased levels of Bag-1 may support the association of this signaling complex and stimulate the increased proliferative rates and cell densities observed in the Bag-1 transfectants. Alternatively, increases in Bag-1 levels may lessen the dependence on other rate-limiting nutrients or growth factors within the medium, thereby enabling enhanced rates of growth.
Like the IL-3-dependent Ba/F3 B-cell line, the PRLdependent Nb2 T cell line has served as an excellent model for examining growth factor signal transduction. Previous studies have shown that treatment of this line with PRL or Dex results in mitogenesis or apoptosis, respectively (16, 17, 40) . Addition of both hormones simultaneously to Nb2 cells inhibited proliferation and diminished, but did not entirely prevent, apoptosis. These in vitro data support several lines of in vivo research, indicating that one mechanism through which the body may regulate its immunoresponsiveness during periods of stress is by alterations in the PRL/Dex balance (11) (12) (13) (68) (69) (70) . As evidenced by the SFJCD1 line, escape from these regulatory mechanisms can impart growth factor independence (17) . The SFJCD1 subline was derived from Nb2; karyotypic analysis has demonstrated that a de novo translocation involving chromosomes 14 and 17 occurred within the SFJCD1 cells (41) . Significant differences in PRLRassociated signaling also exist between these PRLdependent and independent lines. During PRL stimulation of Nb2 cells, the activation of a cascade involving guanine nucleotide exchange factors (Sosand Vav-associated activity), Ras, Raf, and mitogenactivated protein kinase has been documented (71) (72) (73) . In contrast, both the PRL-independent Sp (71) and SFJCD1 cell lines contain a constitutively activated Raf-1, irrespective of the presence of PRL. Thus, these data indicate that some alteration in the inducible PRLR-associated kinase cascade has occurred in SFJCD1 cells. Although many possibilities exist, this up-regulation of Raf-1 kinase activity may result from its allosteric activation secondary to the constitutively elevated levels of Bag-1 found in SFJCD1. Studies to evaluate this hypothesis are currently underway in our laboratory. Nevertheless, these data, coupled with those from the Ba/F3 system, suggest that Bag-1 is involved in the integration of the mitogenic and apoptotic signaling cascades within the hematopoietic and the immune systems.
MATERIALS AND METHODS
Cell Culture
The mouse IL-3-dependent pro-B cell line, Ba/F3 (74), was maintained in RPMI 1640 medium supplemented with 10% FBS and 1% penicillin/streptomycin in the presence of 1 ng IL-3/ml (Prepro-Tech, Rocky Hill, NJ). For experimental purposes this medium was used with varying concentrations of IL-3. The rat pre T cell lymphoma line Nb2/11 (hereafter referred to as Nb2) and the SFJCD1 cell lines (both obtained from Dr. Peter Gout) were cultured in Fisher's medium containing 10% FBS, 10% gelding horse serum, 10 Ϫ4 M ␤-mercaptoethanol, and penicillin/ streptomycin (40, 71) . For experimental purposes, both the Nb2 and SFJCD1 cells were stimulated with varying concentrations of PRL (NIDDK) and Dex (Sigma, St. Louis, MO) in a chemically defined medium consisting of DMEM supplemented with sodium selenite, linoleic acid, insulin, transferrin (ITSϩ supplement, Becton-Dickinson, San Jose, CA), ␤-mercaptoethanol, and penicillin/streptomycin. For some studies, 5 ng PRL/ml and/or 100 nM Dex were used; these concentrations, respectively, have been found to induce maximal cell proliferation (71) or apoptosis (16) . The rates of cell death induced by cytokine withdrawal for Ba/F3 and Nb2 differ and have been well documented (40, 71, 74) ; loss of exogenous IL-3 from the culture medium of Ba/F3 induces 90% cell death by 24-40 h, while removal of PRL from the Nb2 medium induces a similar level of death by 40-60 h. Cell density and viability were assessed by cell labeling with trypan blue; all measurements were performed in triplicate by hemocytometry on at least 200 cells per point.
Apoptosis Measurements
Cell apoptosis was measured by three independent methodologies, as follows: 1) Endonucleolytic DNA cleavage was detected in the Ba/F3 and Nb2 using a commercially available kit (Apoptag, Oncor, Gaithersburg, MD), as described previously (75) . Briefly, 2 ϫ 10 6 washed cells were sequentially fixed in 2% paraformaldehyde and 70% ethanol; DNA cleavage was then detected through the incorporation of ddUTP by terminal deoxynucleotide transferase. To determine the background level of ddUTP incorporation, parallel samples were incubated in the absence of terminal deoxynucleotidyl transferase as a control. Incorporated ddUTP was then subsequently labeled with a fluorescein-conjugated antidigoxigenin antibody. 2) Loss of cellular DNA, as manifest by a hypodiploid DNA content, was measured a described previously (76) . Briefly, 2 ϫ 10 6 washed cells were fixed in 70% ethanol, treated for 20 min with 150 units RNAseA (Worthington Biochemical Corp., Freehold, NJ)/ml, and labeled with 50 g propidium iodide (Calbiochem, San Diego, CA)/ml. 3) Alteration in cellular morphology, as manifest by chromatin condensation, nuclear blebbing, and fragmentation, and cellular shrinkage were assessed by microscopy of Cytospin (Shandon, Sewickley, PA) preparations of 5 ϫ 10 4 cells treated with a DiffQuick stain (3). Although the data from the morphological assessments for apoptosis are not presented here, they confirmed in all cases the data obtained by flow cytometry.
Flow Cytometry
For quantification of both endonucleolytic DNA cleavage and loss of DNA content, 1 ϫ 10 4 cells were analyzed at 488 nm with a FACSTAR flow cytometer (Becton Dickinson) using appropriate filters, as described previously (77) . For ddUTP labeling, control specimens (see above) were used to determine the cut-off below which 98% of the negative cells fell.
Immunoblot Analysis
Immunoblot analysis was performed as described previously (39) with modifications. Approximately 5 ϫ 10 5 washed cells resuspended in 2ϫ Laemmli buffer were subjected to 10% SDS-PAGE and transferred to nitrocellulose. The blot was blocked with a TN-TBM solution that consisted of 10 mM Tris (pH 7.7), 150 mM NaCl, 0.01% Triton X-100, 2% BSA, fraction V (Sigma), 5% non-fat dried skim milk, and 0.01% NaN 3 . Antigen was detected with a rabbit anti-mouse Bag-1 antiserum (39) at a 1:1000 (vol/vol) dilution in the TN-TBM buffer containing 1 l normal goat serum and 50 ng/ml ovalbumin (Sigma). Parallel control blots were probed with preimmune rabbit serum. Antigen-antibody complexes were then detected using enhanced chemiluminescence (ECL kit, Amersham, Arlington Heights, IL).
Cell Transfection
For constitutive overexpression of Bag-1, full-length murine Bag-1 cDNA was subcloned into the BamHI site of NeopCMV, which contains the neomycin resistance gene and a CMV promoter/enhancer element upstream of the BamHI insertion site. Ba/F3 cells (1.5 ϫ 10 7 ) were transfected with 50 g of linearized empty vector (Neo-pCMV) or vector containing Bag-1 (Bag1-pCMV) by electroporation (78) . Stable transfectants were generated by selection with G418, and clones were obtained by limiting dilution. Five independent clones from each transfection were selected on the basis of highest levels of Bag-1 expression as determined by immunoblot analysis. Although the data shown here are from two independent clones, comparable results were obtained for each of the five transfectants overexpressing Bag-1.
Statistics
Quantitative analyses of Bag-1 levels were obtained by scanning densitometry (Molecular Dynamics, Sunnyvale, CA) of anti-Bag-1 immunoblots. Unless otherwise indicated, all experiments were performed in triplicate and reported as mean values; where not visible, error bars (Ϯ SEM) lie within the symbol's diameter.
